Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Post-SARS-CoV-2 Vaccinal Response in Immunocompromised Patients

NCT05672654 is registered in ClinicalTrials.gov with University Hospital, Ghent as lead sponsor.

NCT NCT05672654
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05672654 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Post-SARS-CoV-2 Vaccinal Response in Immunocompromised Patients
Lead sponsor
University Hospital, Ghent
Phase
Not applicable
Overall status
Withdrawn
Start date
May 10, 2021
Completion date
September 1, 2023
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19, hiv seropositivity, immunodeficiency, vaccination reaction